Immunotherapy: PD-1 Antibodies and Beyond- Dr. Carvajal Melanoma Education Symposium 2014

Dr. Carvajal, Director of Developmental Therapeutics and Assistant Attending Physician at Memorial Sloan Kettering Cancer Center describes the future of immunotherapy and clinical trials for metastatic melanoma.

Agency: BoldSpark
Director: Sean Willis
BoldSparkCollective.com

• категория